TREA

98731337 - COSUNTER

Follow

Information

  • Trademark
  • 98731337
  • Serial Number
    98731337
  • Filing Date
    September 03, 2024
    a year ago
  • Transaction Date
    June 24, 2025
    5 months ago
  • Status Date
    June 24, 2025
    5 months ago
  • Published for Opposition Date
    June 24, 2025
    5 months ago
  • Location Date
    June 03, 2025
    6 months ago
  • Status Code
    686
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    MOLINOFF, JEFFREY
  • Attorney Docket Number
    BYL0198TUS
    Attorney Name
    Michelle P. Ciotola
    Law Office Assigned Location Code
    N40
  • Owners
Information
Mark Drawing Code
4
Mark Identification
COSUNTER
Case File Statements
  • GS0051: Nutritive substances for microorganisms for medical purposes; Medicines made of Chinese traditional medicinal herbs, for the treatment of COVID-19, upper respiratory tract infections, chest congestion, shortness of breath, chronic chest diseases, fever, influenza, tracheitis, cancer, hepatitis, cirrhosis, liver diseases and disorders, gallstones, hepatopathy, Acquired Immune Deficiency Syndrome (AIDS), gastritis, gastralgia, poor appetite, muscle weakness, abdominal distension, erectile dysfunction, premature ejaculation, benign prostatic hyperplasia, thrombus, pulmonary embolism, hypercholesterolemia, adiposity, insomnia, amnesia, asthenia, neurasthenia, vertigo, cough; Medicinal preparations for human use, the treatment of COVID-19, upper respiratory tract infections, chest congestion, shortness of breath, chronic chest diseases, fever, influenza, tracheitis, cancer, hepatitis, cirrhosis, liver diseases and disorders, gallstones, hepatopathy, Acquired Immune Deficiency Syndrome (AIDS), gastritis, gastralgia, poor appetite, muscle weakness, abdominal distension, erectile dysfunction, premature ejaculation, benign prostatic hyperplasia, thrombus, pulmonary embolism, hypercholesterolemia, adiposity, insomnia, amnesia, asthenia, neurasthenia, vertigo, cough; Drugs for medical purposes, namely, medicaments for the treatment of COVID-19, upper respiratory tract infections, chest congestion, shortness of breath, chronic chest diseases, fever, influenza, tracheitis, cancer, hepatitis, cirrhosis, liver diseases and disorders, gallstones, hepatopathy, Acquired Immune Deficiency Syndrome (AIDS), gastritis, gastralgia, poor appetite, muscle weakness, abdominal distension, erectile dysfunction, premature ejaculation, benign prostatic hyperplasia, thrombus, pulmonary embolism, hypercholesterolemia, adiposity, insomnia, amnesia, asthenia, neurasthenia, vertigo, cough; Pharmaceutical preparations, for the treatment of COVID-19, upper respiratory tract infections, chest congestion, shortness of breath, chronic chest diseases, fever, influenza, tracheitis, cancer, hepatitis, cirrhosis, liver diseases and disorders, gallstones, hepatopathy, Acquired Immune Deficiency Syndrome (AIDS), gastritis, gastralgia, poor appetite, muscle weakness, abdominal distension, erectile dysfunction, premature ejaculation, benign prostatic hyperplasia, thrombus, pulmonary embolism, hypercholesterolemia, adiposity, insomnia, amnesia, asthenia, neurasthenia, vertigo, cough; Crude drugs, namely, medicinal preparations for the treatment of COVID-19, upper respiratory tract infections, chest congestion, shortness of breath, chronic chest diseases, fever, influenza, tracheitis, cancer, hepatitis, cirrhosis, liver diseases and disorders, gallstones, hepatopathy, Acquired Immune Deficiency Syndrome (AIDS), gastritis, gastralgia, poor appetite, muscle weakness, abdominal distension, erectile dysfunction, premature ejaculation, benign prostatic hyperplasia, thrombus, pulmonary embolism, hypercholesterolemia, adiposity, insomnia, amnesia, asthenia, neurasthenia, vertigo, cough; Biochemical medicinal preparations for the treatment of COVID-19, upper respiratory tract infections, chest congestion, shortness of breath, chronic chest diseases, fever, influenza, tracheitis, cancer, hepatitis, cirrhosis, liver diseases and disorders, gallstones, hepatopathy, Acquired Immune Deficiency Syndrome (AIDS), gastritis, gastralgia, poor appetite, muscle weakness, abdominal distension, erectile dysfunction, premature ejaculation, benign prostatic hyperplasia, thrombus, pulmonary embolism, hypercholesterolemia, adiposity, insomnia, amnesia, asthenia, neurasthenia, vertigo, cough; Medicinal tea; Dietetic foods and beverages adapted for medical use; Dietetic preparations adapted for medical purpose
Case File Event Statements
  • 9/3/2024 - a year ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 9/3/2024 - a year ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 3/6/2025 - 9 months ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 3/21/2025 - 8 months ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 3/21/2025 - 8 months ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 3/21/2025 - 8 months ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 5/13/2025 - 6 months ago
    9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 5/13/2025 - 6 months ago
    8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 5/13/2025 - 6 months ago
    10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 5/21/2025 - 6 months ago
    11 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 6/18/2025 - 5 months ago
    12 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 6/24/2025 - 5 months ago
    13 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 6/24/2025 - 5 months ago
    14 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 4/7/2025 - 8 months ago
    7 - ASSIGNED TO EXAMINER Type: DOCK